NCT00602433View on ClinicalTrials.gov

Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Advanced Nonsmall Cell Lung Cancer
Trial Locations (1)

60611-3013

Northwestern University, Northwestern Medical Faculty Foundation, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT00602433 - Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib | Biotech Hunter | Biotech Hunter